Eicosapentaenoic Acid Market by Source (Algae, Fish, Krill), Form (Ethyl Esters, Triglycerides), Application - Global Forecast 2024-2030

Eicosapentaenoic Acid Market by Source (Algae, Fish, Krill), Form (Ethyl Esters, Triglycerides), Application - Global Forecast 2024-2030

The Eicosapentaenoic Acid Market size was estimated at USD 862.50 million in 2023 and expected to reach USD 904.94 million in 2024, at a CAGR 5.16% to reach USD 1,227.44 million by 2030.

Eicosapentaenoic acid (EPA) is a long-chain omega-3 fatty acid primarily found in oily fish, fish oil supplements, and certain algae. The market for EPA encompasses its production, purification, and applications across various industries. The terrain of the EPA market includes pharmaceuticals, dietary supplements, food & beverages, and animal nutrition, highlighting its diversification in usage and end-consumer benefits. The scope of the EPA market is expanding, with innovation driving into new applications, including biofuels and bioplastics, indicating a broad horizon for growth and development. Growing consumer awareness regarding health and wellness, alongside the desire for natural dietary supplements, significantly drives the demand for EPA. Continuous research substantiating EPA’s efficacy in treating and managing various health conditions bolsters its adoption in pharmaceuticals. Favorable regulations encouraging the use of omega-3s in food and dietary supplements positively affect market growth. Growing attention to sustainable sources of EPA, including microalgae, presents a significant opportunity for eco-conscious market adaptation. Additionally, rising pet healthcare expenditures are also expected to boost the scope for eicosapentaenoic acid within animal nutrition segments.

Regional Insights

The Americas represent a significant market for eicosapentaenoic acid (EPA) owing to the high awareness of omega-3 benefits among consumers and well-established healthcare sectors. The region shows a robust demand for EPA in dietary supplements due to the growing emphasis on preventive healthcare and an aging population prone to cardiovascular diseases. The U.S. holds a significant position in the pharmaceutical sector, where EPA is extensively utilized in formulations aimed at treating conditions including hypertriglyceridemia. The regulatory support from agencies including the FDA for omega-3-based therapeutic products further scaffolds the market growth in this region. The presence of major market players, coupled with aggressive marketing strategies and consumer education on the benefits of omega-3 fatty acids, bolsters the market expansion. The Asia-Pacific region is experiencing rapid growth in the eicosapentaenoic acid market, driven by rising health consciousness and disposable incomes, especially in countries including China, Japan, and India. Japan, being one of the largest consumers of EPA, holds a significant market share due to its traditional diet rich in fish. The region is witnessing a surge in the demand for dietary supplements as consumers are increasingly inclined towards preventive healthcare measures. Additionally, the expansion of the pharmaceutical sector in APAC countries, aimed at developing advanced treatment options for cardiovascular and neurodegenerative diseases, further propels the demand for EPA. Innovation in product development, coupled with an increase in the aquaculture industry, specifically focusing on EPA-rich fish farming, is set to boost the market's growth potential in this region. The EMEA region exhibits a growing interest in Eicosapentaenoic Acid, with Europe leading the charge. The increasing awareness about the benefits of omega-3 fatty acids, coupled with a rising elderly population susceptible to chronic diseases, fuels the demand for EPA-enriched dietary supplements. European countries, with their stringent regulatory frameworks for nutritional products, present a promising market for high-quality, EPA-based pharmaceuticals. The Middle East and Africa are emerging markets with vast growth potential, attributed to a gradual shift towards health and wellness trends and improving healthcare infrastructure. While Europe's mature market focuses on innovation and stringent quality standards, the Middle East and Africa offer untapped opportunities driven by economic diversification and an increasing focus on preventive healthcare.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Eicosapentaenoic Acid Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

Significance of EPA for lowering risk of rising prevalence of chronic diseases
Rise in spending on nutritional and infant food products

Market Restraints

Issues associated with availability of raw materials required for EPA

Market Opportunities

Introduction of sustainable and vegan EPA
Rising investments to expand EPA offerings

Market Challenges

Possibilities of side effects associated with consumption of EPA

Market Segmentation Analysis

Source: Growing usage of algal oil that provides a sustainable alternative and meets the ongoing trend of plant-based diets
Application: Rising potential of eicosapentaenoic acid in functional food & beverages to provide added health benefits

Market Disruption Analysis

Porter’s Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Eicosapentaenoic Acid Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Eicosapentaenoic Acid Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Amneal Expands Portfolio with Addition of Icosapent Ethyl Acid Soft Gel Capsules

Amneal Pharmaceuticals, Inc. and Strides Pharma Science Limited announced their strategic collaboration for the introduction of Icosapent Ethyl soft gel capsules, a VASCEPA reference product. This innovative product, available in 0.5g and 1g dosages, is an adjunctive treatment to dietary adjustments to lower triglyceride levels in adults with severe hypertriglyceridemia (≥500 mg/dL).

Biomar Forms Partnership to Commercialise Omega-3 Camelina

BioMar, a producer of salmon feed, entered into a strategic partnership with Yield10 Bioscience, a U.S.-based company, to bring to market a revolutionary genetically modified oilseed crop rich in omega-3 fatty acids EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), matching the levels found in traditional fish oil. This innovation presents a land-based, sustainable alternative for sourcing omega-3s, essential components in aquaculture feeds.

Amarin and Neopharm Announce Exclusive Commercialization Agreement for Vazkepa (Icosapent Ethyl) in Israel

Amarin Corporation plc and Neopharm Israel officially announced their exclusive partnership for the marketing and commercializing of VAZKEPA (icosapent ethyl) in Israel, Gaza, the West Bank, and territories under the Palestinian Authority. VAZKEPA capsules, featuring icosapent ethyl as their sole active ingredient—a highly purified form of eicosapentaenoic acid—represent the first prescription therapy of its kind. This strategic alliance leverages Neopharm's significant expertise and strong presence in cardiology to ensure VAZKEPA's accessibility to patients in need, especially those at elevated cardiovascular risk.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Eicosapentaenoic Acid Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Eicosapentaenoic Acid Market, highlighting leading vendors and their innovative profiles. These include AlgiSys BioSciences Inc., Archer Daniels Midland Company, Arctic Nutrition AG, Asterisk Laboratories (I) Pvt. Ltd., BASF SE, BIOSEARCH, SA, Cayman Chemical Company, Corbion N.V., Croda International PLC, Epax Norway AS, Evonik Industries AG, Golden Omega S.A., Indo Rama Engineers, KD Pharma Group, Koninklijke DSM N.V., Novasep Holding SAS, Novotech Nutraceuticals, Inc., Omega Protein Corporation, Orkla Health AS, Pelagia AS, Santa Cruz Biotechnology, Inc., Shandong Yuwang Pharmaceutical Co., Ltd., SimSon Pharma Limited, Sinomega Biotech Engineering Co.,Ltd., and Toronto Research Chemicals Inc..

Market Segmentation & Coverage

This research report categorizes the Eicosapentaenoic Acid Market to forecast the revenues and analyze trends in each of the following sub-markets:

Source
Algae
Fish
Krill
Form
Ethyl Esters
Triglycerides
Application
Dietary Supplements
Functional Food & Beverages
Pharmaceuticals
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

Please Note: PDF & Excel + Online Access - 1 Year Show more